<DOC>
	<DOCNO>NCT01982032</DOCNO>
	<brief_summary>Transcatheter aortic valve replacement ( TAVR ) good alternative treatment patient severe aortic valve stenosis similar mid-term success rate compare surgery . Periprosthetic aortic regurgitation ( PAR ) TAVR remain important limitation technique . Moderate severe PAR occur 15-45 % case independent predictor mortality TAVR . Little known potential difference severity PAR among different type aortic valve prosthesis . The current randomized study aim evaluate potential difference Edwards SAPIEN bioprosthesis Medtronic CoreValve® system main focus PAR additional focus clinical imaging endpoint . Primary objective study investigate difference severity PAR , measure 3-dimensional transesophageal echocardiography ( 3DTEE ) , patient undergo implantation Edwards SAPIEN bioprosthesis versus patient receive Medtronic CoreValve® bioprosthesis . Secondary objective study include : investigate value different image modality evaluate periprosthetic regurgitation TAVR study difference clinical endpoint accord VARC-2 definition quality life TAVR two available aortic valve prosthesis .</brief_summary>
	<brief_title>Edwards SAPIEN Periprosthetic Leakage Evaluation Versus Medtronic CoreValve Transfemoral Aortic Valve Implantation ( ELECT Trial )</brief_title>
	<detailed_description />
	<mesh_term>Aortic Valve Insufficiency</mesh_term>
	<criteria>Inclusion criterion In order eligible participate study , subject must meet following criterion : Patient ≥18 year age diagnose severe symptomatic aortic stenosis , judge inoperable high surgical risk ( EuroSCORE &gt; 15 % criterion make surgery high risk consensus among cardiologist cardiac surgeon heart team ) deem eligible transfemoralTAVI . Aortic annulus diameter ≥ 18 ≤ 29 mm assess MSCT . No contraindication study requirement MRI TEE . Exclusion criteria Patients unable unwilling give inform consent . Patients exclude study size aortic annulus diameter .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Periprosthetic aortic valve regurgitation</keyword>
	<keyword>3D transesophageal echocardiography</keyword>
	<keyword>Cardiac MRI</keyword>
</DOC>